Biden Calls for Cheaper Ozempic

from Rebel's Edge with Jon & Pete Najarian

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Novo Nordisk biggest loser day after Biden calls for cheaper Ozempic, Barry Diller's bid to take control of Paramount Global, Tesla spiking on higher-than-expected EV deliveries, and Ardelyx backing off from a new treatment use-case. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the Celtics payroll and the Atlanta Falcons prospects for the coming season. Stay on the cutting edge with Rebel's Edge.

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

Biden Calls for Cheaper Ozempic

0:00 26:57

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently asked questions

How long is this episode of Rebel's Edge with Jon & Pete Najarian?

This episode is 26 minutes long.

When was this Rebel's Edge with Jon & Pete Najarian episode published?

This episode was published on July 2, 2024.

Can I download this Rebel's Edge with Jon & Pete Najarian episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.